Your browser doesn't support javascript.
loading
Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap.
Gray, Glenda E; Mayer, Kenneth H; Elizaga, Marnie L; Bekker, Linda-Gail; Allen, Mary; Morris, Lynn; Montefiori, David; De Rosa, Stephen C; Sato, Alicia; Gu, Niya; Tomaras, Georgia D; Tucker, Timothy; Barnett, Susan W; Mkhize, Nonhlanhla N; Shen, Xiaoying; Downing, Katrina; Williamson, Carolyn; Pensiero, Michael; Corey, Lawrence; Williamson, Anna-Lise.
Afiliação
  • Gray GE; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa Glenda.gray@mrc.ac.za.
  • Mayer KH; South African Medical Research Council, Cape Town, South Africa.
  • Elizaga ML; Fenway Health and Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Bekker LG; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Allen M; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Morris L; DAIDS, NIAID, NIH, Washington, DC, USA.
  • Montefiori D; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • De Rosa SC; Duke University, Durham, North Carolina, USA.
  • Sato A; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Gu N; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Tomaras GD; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Tucker T; Duke University, Durham, North Carolina, USA.
  • Barnett SW; South African Medical Research Council, Cape Town, South Africa.
  • Mkhize NN; Novartis Vaccines, Cambridge, Massachusetts, USA.
  • Shen X; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Downing K; Duke University, Durham, North Carolina, USA.
  • Williamson C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Pensiero M; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Corey L; National Health Laboratory Service, Cape Town, South Africa.
  • Williamson AL; DAIDS, NIAID, NIH, Washington, DC, USA.
Clin Vaccine Immunol ; 23(6): 496-506, 2016 06.
Article em En | MEDLINE | ID: mdl-27098021
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome da Imunodeficiência Adquirida / Esquemas de Imunização / Imunização Secundária / Vacinas contra a AIDS / Vacinas de DNA / Produtos do Gene env do Vírus da Imunodeficiência Humana / Anticorpos Neutralizantes Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male País como assunto: Africa Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome da Imunodeficiência Adquirida / Esquemas de Imunização / Imunização Secundária / Vacinas contra a AIDS / Vacinas de DNA / Produtos do Gene env do Vírus da Imunodeficiência Humana / Anticorpos Neutralizantes Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male País como assunto: Africa Idioma: En Ano de publicação: 2016 Tipo de documento: Article